Drug platforms; drug delivery

TECHNOLOGY: Nucleic acids; other

A method for delivering bispecific T cell-engaging antibodies as engineered mRNAs could prolong the serum half-life of the antibodies to treat cancer. mRNA encoding

Read the full 270 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE